CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,622,000 | +22.0% | 200,000 | -33.3% | 0.73% | -24.5% |
| Q3 2020 | $25,092,000 | -14.6% | 300,000 | -25.0% | 0.96% | -14.0% |
| Q2 2020 | $29,396,000 | +10.0% | 400,000 | -36.5% | 1.12% | -9.7% |
| Q1 2020 | $26,735,000 | -56.1% | 630,400 | -37.0% | 1.24% | -48.9% |
| Q4 2019 | $60,905,000 | +37.0% | 1,000,000 | -7.8% | 2.43% | -10.2% |
| Q3 2019 | $44,445,000 | +34.8% | 1,084,300 | +54.9% | 2.70% | +42.8% |
| Q2 2019 | $32,970,000 | +2.6% | 700,000 | -22.2% | 1.89% | -12.8% |
| Q1 2019 | $32,148,000 | +1025.2% | 900,000 | +800.0% | 2.17% | +836.6% |
| Q4 2018 | $2,857,000 | – | 100,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |